Most Read Articles
Roshini Claire Anthony, 4 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Elvira Manzano, 5 days ago
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
3 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.

Exposure to cigarette smoke, air pollution ups risk of juvenile idiopathic arthritis

08 Feb 2018

Exposure to ozone (O3) in the second year of life and cigarette smoke (intrauterine and after birth) and maternal occupational exposure may increase the risk of juvenile idiopathic arthritis (JIA), suggests a recent study.

Intrauterine cigarette smoke exposure (odds ratio [OR], 3.43; 95 percent CI, 1.45‒8.12; p=0.005) and maternal occupational exposure (OR, 13.69; 4.4‒42.3; p<0.001) during pregnancy significantly independently predicted JIA. On the other hand, maternal employment (OR, 0.06; 0.02‒0.2; p<0.001) and ideal maternal weight gain (OR, 0.36; 0.2‒0.8; p=0.017) showed negative associations.

Furthermore, secondhand smoke exposure from birth to JIA diagnosis (OR, 3.6; 1.8‒7.3; p<0.001) and O3 exposure during the second year of life (OR, 2.76; 1.20‒6.37; p=0.017) were significant independent risk factors for the development of JIA.

A total of 66 patients with JIA and 124 age- and sex-matched healthy controls, living in Sao Paulo, Brazil, metropolitan area until JIA diagnosis, and whose mothers resided in this region during pregnancy were included in this exploratory case-control study.

The authors used a structured and reliable questionnaire (κ index for test-retest was 0.80) to analyse demographic data, gestational and perinatal-related factors, and exposure to inhalable environmental elements during pregnancy and after birth (occupational exposure to inhalable particles or volatile vapour, cigarette smoke exposure, and presence of industrial activities or gas stations near the home, work, daycare or school).

Tropospheric pollutants included particulate matter, sulphur dioxide, nitrogen dioxide, O3 and carbon monoxide.

The finding of an association between JIA and exposure to cigarette smoke and air pollution warrants further study, according to the authors.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Elvira Manzano, 5 days ago
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
3 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.